Annual CFF
-$49.10 M
+$45.10 M+47.88%
December 31, 2024
Summary
- As of March 12, 2025, AVNS annual cash flow from financing activities is -$49.10 million, with the most recent change of +$45.10 million (+47.88%) on December 31, 2024.
- During the last 3 years, AVNS annual CFF has risen by +$6.20 million (+11.21%).
- AVNS annual CFF is now -186.60% below its all-time high of $56.70 million, reached on December 31, 2022.
Performance
AVNS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
-$27.40 M
-$11.40 M-71.25%
December 31, 2024
Summary
- As of March 12, 2025, AVNS quarterly cash flow from financing activities is -$27.40 million, with the most recent change of -$11.40 million (-71.25%) on December 31, 2024.
- Over the past year, AVNS quarterly CFF has increased by +$87.30 million (+76.11%).
- AVNS quarterly CFF is now -125.92% below its all-time high of $105.70 million, reached on March 31, 2022.
Performance
AVNS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$49.10 M
+$87.30 M+64.00%
December 31, 2024
Summary
- As of March 12, 2025, AVNS TTM cash flow from financing activities is -$49.10 million, with the most recent change of +$87.30 million (+64.00%) on December 31, 2024.
- Over the past year, AVNS TTM CFF has increased by +$45.10 million (+47.88%).
- AVNS TTM CFF is now -186.60% below its all-time high of $56.70 million, reached on December 31, 2022.
Performance
AVNS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AVNS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +47.9% | +76.1% | +47.9% |
| 3 y3 years | +11.2% | -125.9% | -197.0% |
| 5 y5 years | -3373.3% | -125.9% | -197.0% |
AVNS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -186.6% | +47.9% | -125.9% | +76.1% | -186.6% | +64.0% |
| 5 y | 5-year | -186.6% | +47.9% | -125.9% | +76.1% | -186.6% | +64.0% |
| alltime | all time | -186.6% | +84.9% | -125.9% | +90.6% | -186.6% | +84.9% |
Avanos Medical Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$49.10 M(-47.9%) | -$27.40 M(+71.3%) | -$49.10 M(-64.0%) |
| Sep 2024 | - | -$16.00 M(+220.0%) | -$136.40 M(+85.1%) |
| Jun 2024 | - | -$5.00 M(+614.3%) | -$73.70 M(+1.2%) |
| Mar 2024 | - | -$700.00 K(-99.4%) | -$72.80 M(-22.7%) |
| Dec 2023 | -$94.20 M(-266.1%) | -$114.70 M(-345.6%) | -$94.20 M(+6628.6%) |
| Sep 2023 | - | $46.70 M(-1239.0%) | -$1.40 M(-97.6%) |
| Jun 2023 | - | -$4.10 M(-81.4%) | -$58.30 M(-18.0%) |
| Mar 2023 | - | -$22.10 M(+0.9%) | -$71.10 M(-225.4%) |
| Dec 2022 | $56.70 M(-202.5%) | -$21.90 M(+114.7%) | $56.70 M(+7.4%) |
| Sep 2022 | - | -$10.20 M(-39.6%) | $52.80 M(+20.5%) |
| Jun 2022 | - | -$16.90 M(-116.0%) | $43.80 M(-13.4%) |
| Mar 2022 | - | $105.70 M(-509.7%) | $50.60 M(-191.5%) |
| Dec 2021 | -$55.30 M(-21.0%) | -$25.80 M(+34.4%) | -$55.30 M(-43.5%) |
| Sep 2021 | - | -$19.20 M(+90.1%) | -$97.80 M(+21.3%) |
| Jun 2021 | - | -$10.10 M(+4950.0%) | -$80.60 M(+14.8%) |
| Mar 2021 | - | -$200.00 K(-99.7%) | -$70.20 M(+0.3%) |
| Dec 2020 | -$70.00 M(-4766.7%) | -$68.30 M(+3315.0%) | -$70.00 M(+3788.9%) |
| Sep 2020 | - | -$2.00 M(-766.7%) | -$1.80 M(-166.7%) |
| Jun 2020 | - | $300.00 K(>+9900.0%) | $2.70 M(-15.6%) |
| Mar 2020 | - | $0.00(-100.0%) | $3.20 M(+113.3%) |
| Dec 2019 | $1.50 M(-100.5%) | -$100.00 K(-104.0%) | $1.50 M(>+9900.0%) |
| Sep 2019 | - | $2.50 M(+212.5%) | $0.00(-100.0%) |
| Jun 2019 | - | $800.00 K(-147.1%) | $2.90 M(-101.0%) |
| Mar 2019 | - | -$1.70 M(+6.3%) | -$289.40 M(-10.8%) |
| Dec 2018 | -$324.40 M | -$1.60 M(-129.6%) | -$324.40 M(+1.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | $5.40 M(-101.9%) | -$320.90 M(-1.2%) |
| Jun 2018 | - | -$291.50 M(+694.3%) | -$324.80 M(+828.0%) |
| Mar 2018 | - | -$36.70 M(-2031.6%) | -$35.00 M(-1690.9%) |
| Dec 2017 | $2.20 M(-257.1%) | $1.90 M(+26.7%) | $2.20 M(-121.2%) |
| Sep 2017 | - | $1.50 M(-188.2%) | -$10.40 M(-77.7%) |
| Jun 2017 | - | -$1.70 M(-440.0%) | -$46.70 M(+5088.9%) |
| Mar 2017 | - | $500.00 K(-104.7%) | -$900.00 K(-35.7%) |
| Dec 2016 | -$1.40 M(-97.2%) | -$10.70 M(-69.3%) | -$1.40 M(-114.7%) |
| Sep 2016 | - | -$34.80 M(-178.9%) | $9.50 M(-78.7%) |
| Jun 2016 | - | $44.10 M(>+9900.0%) | $44.60 M(-189.9%) |
| Mar 2016 | - | $0.00(-100.0%) | -$49.60 M(-2.0%) |
| Dec 2015 | -$50.60 M(-273.3%) | $200.00 K(-33.3%) | -$50.60 M(-568.5%) |
| Sep 2015 | - | $300.00 K(-100.6%) | $10.80 M(-62.6%) |
| Jun 2015 | - | -$50.10 M(+4910.0%) | $28.90 M(-46.8%) |
| Mar 2015 | - | -$1.00 M(-101.6%) | $54.30 M(+86.0%) |
| Dec 2014 | $29.20 M(-116.2%) | $61.60 M(+234.8%) | $29.20 M(-129.2%) |
| Sep 2014 | - | $18.40 M(-174.5%) | -$99.90 M(-41.0%) |
| Jun 2014 | - | -$24.70 M(-5.4%) | -$169.30 M(-4.6%) |
| Mar 2014 | - | -$26.10 M(-61.3%) | -$177.40 M(-1.4%) |
| Dec 2013 | -$180.00 M(+34.4%) | -$67.50 M(+32.4%) | -$180.00 M(+60.0%) |
| Sep 2013 | - | -$51.00 M(+55.5%) | -$112.50 M(+82.9%) |
| Jun 2013 | - | -$32.80 M(+14.3%) | -$61.50 M(+114.3%) |
| Mar 2013 | - | -$28.70 M | -$28.70 M |
| Dec 2012 | -$133.90 M(+16.3%) | - | - |
| Dec 2011 | -$115.10 M | - | - |
FAQ
- What is Avanos Medical annual cash flow from financing activities?
- What is the all time high annual CFF for Avanos Medical?
- What is Avanos Medical annual CFF year-on-year change?
- What is Avanos Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Avanos Medical?
- What is Avanos Medical quarterly CFF year-on-year change?
- What is Avanos Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Avanos Medical?
- What is Avanos Medical TTM CFF year-on-year change?
What is Avanos Medical annual cash flow from financing activities?
The current annual CFF of AVNS is -$49.10 M
What is the all time high annual CFF for Avanos Medical?
Avanos Medical all-time high annual cash flow from financing activities is $56.70 M
What is Avanos Medical annual CFF year-on-year change?
Over the past year, AVNS annual cash flow from financing activities has changed by +$45.10 M (+47.88%)
What is Avanos Medical quarterly cash flow from financing activities?
The current quarterly CFF of AVNS is -$27.40 M
What is the all time high quarterly CFF for Avanos Medical?
Avanos Medical all-time high quarterly cash flow from financing activities is $105.70 M
What is Avanos Medical quarterly CFF year-on-year change?
Over the past year, AVNS quarterly cash flow from financing activities has changed by +$87.30 M (+76.11%)
What is Avanos Medical TTM cash flow from financing activities?
The current TTM CFF of AVNS is -$49.10 M
What is the all time high TTM CFF for Avanos Medical?
Avanos Medical all-time high TTM cash flow from financing activities is $56.70 M
What is Avanos Medical TTM CFF year-on-year change?
Over the past year, AVNS TTM cash flow from financing activities has changed by +$45.10 M (+47.88%)